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Enzymatic-detergentdecellularizationtreatmentsmayuseacombinationofchemicalreagentstoreducevasculartissuetosterilized
scaﬀolds, which may be seeded with endothelial cells and implanted with a low risk of rejection. However, these chemicals may
alter the mechanical properties of the native tissue and contribute to graft compliance mismatch. Uniaxial tensile data obtained
from native and decellularized longitudinal aortic tissue samples was analyzed in terms of engineering stress and ﬁt to a modiﬁed
form of the Yeoh rubber model. One decellularization protocol used SDS, while the other two used TritonX-100, RNase-A, and
DNase-I in combination with EDTA or sodium-deoxycholate. Statistical signiﬁcance of Yeoh model parameters was determined
by paired t-test analysis. The TritonX-100/EDTA and 0.075% SDS treatments resulted in relatively variable mechanical changes
and did not eﬀectively lyse VSMCs in aortic tissue. The TritonX-100/sodium-deoxycholate treatment eﬀectively lysed VSMCs and
was characterized by less variability in mechanical behavior. The data suggests a TritonX-100/sodium-deoxycholate treatment is a
moreeﬀectiveoptionthanTritonX-100/EDTAandSDStreatmentsforthepreparationofaorticxenograftsandallograftsbecauseit
eﬀectively lyses VSMCsand istheleast likely treatment,amongthoseconsidered, to promoteadecrease inmechanical compliance.
1.Introduction
In the United States, there are over 500,000 arterial bypass
operationsperformedeachyear[1–3].Autologousvesselsare
preferred as graft materials, however, up to 40% of patients
needing bypass surgery may not have a healthy artery or
saphenous vein of suitable length for use as an autograft [4].
Even if suitable venous tissue is available for transplantation,
in vivo remodeling due to injury or increased loading may
cause occlusion of the vessel [5, 6]. While synthetic grafts
are currently the standard clinical alternative to autologous
grafts, there are relative diﬀerences in mechanical properties
between grafts formed from these materials and the native
vasculature. As a result, the patient’s native artery will
biologically remodel itself to compensate for this mechanical
diﬀerence and excessive remodeling may occlude the artery.
This excessive thickening, called intimal hyperplasia, is the
main mode of occlusive graft failure and results in low long-
term patency rates for small-diameter arterial grafts.
Synthetic grafts such as Dacron (polyethylene terephtha-
late) and expanded polytetraﬂouroethylene (ePTFE) func-
tion exceptionally well under high ﬂow, low-resistance
conditions. Both Dacron and ePTFE have had great success
in replacing large diameter vessels, maintaining a reported
90% patency rate after ﬁve-years as an aortiobifemoral
graft [7]. While ePTFE grafts have been commercially
available for transplant for over 40 years, these grafts have
a 20% decreased patency rate over a ﬁve year period
when compared with autologous saphenous vein grafts for
femoropopliteal bypass procedures [8], and are known to
elicit thrombotic complications when used for peripheral
bypass applications, eﬀectively decreasing their long term
patency [9, 10].
In light of the complications associated with small-
diameter synthetic grafts, there have been eﬀorts to create
a tissue-engineered blood vessel in vitro, but these vessels
are susceptible to rupture and are not a timely solution
[11–15]. Recent studies on arterial allografts [16–18]a n d2 International Journal of Biomaterials
Figure 1: Longitudinal sample preparation: cuts made on dashed lines, similarly cross-hatched sections are paired samples.
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Figure 2: Example of hysteresis in native and acellular tissue
samples for 4 load-unload cycles.
xenografts [14, 19–21] have shown that an arterial extra-
cellular matrix may be preserved and seeded with the
host’s endothelial cells to prevent immunogenic rejection.
These processes are advantageous because the graft is
available in days rather than weeks or months. Xenogenic
extracellular matrices isolated from various tissues of sus
scrofa domesticus, the common domesticated pig, have been
used as a scaﬀold for a variety of tissue engineering
applications including lower urinary tract reconstruction,
skin reconstruction, orthopaedic applications, and arterial
grafts [22]. Acellular xenogeneic scaﬀolds have the unique
potential for host cell recolonization without inducing an
immunogenic response [23], since the amino acid sequence
and quaternary structure of many extracellular matrix
proteins are highly conserved among various species [22,
24]. The availability of suitable synthetic, allogeneic, or
xenogenic graft scaﬀolds for small-diameter arteries would
greatly aid patients needing coronary or peripheral bypass
surgery.
The goal of any decellularization procedure is to remove
all of the cellular components from the extracellular matrix
while preserving its biological activity and mechanical
integrity. Decellularization protocols may involve any com-
bination of physical, chemical or enzymatic methods and
utilize a variety of detergents, enzymes or solvents to lyse the
native smooth muscle cells (VSMCs) from the extracellular
matrix [24]. The treatments eﬀectively reduce antigenicity
while creating free volume spaces upon which the host’s
native cells are able to proliferate [25, 26].
Among the various decellularization procedures in lit-
erature, we compared the eﬀects of three well-established
enzymatic-and-detergent treatments [25, 27, 28]. One of
the tested protocols uses SDS as the sole reagent, while the
remaining two use RNase A, DNase I, and TritonX-100 in
combination with EDTA or sodium-deoxycholate (the salt
of deoxycholic acid). The selected protocols have been used
to successfully decellularize porcine heart valve roots and
leaﬂets [25, 27, 29–36] but will be extended to fully intact
porcine arterial tissue segments for the ﬁrst time in this
study.
The selected TritonX-100/EDTA treatment was used
successfully as a decellularization method in heart valve
decellularization-recellularization studies [27, 29]b u tw a s
then used without RNase when decellularizing porcine
artery without its adventitial layer by Dahl et al. [37]w h o
found no signiﬁcant diﬀerence in DNA content between
treated and untreated vessels. Booth et al. championed
0.03%–1% SDS and 0.5%–2% deoxycholic acid treatments
as successful decellularization techniques for porcine heart
valves [31]. Since then, Reider et al. reported diﬃculty with
recellularizing vessels after decellularization in 0.1% SDS
solution and Kasimir et al. also noticed disintegration of
matrix ﬁbers during SEM analysis following a 0.03% SDS
treatment [33, 34]. Deoxycholic acid treatments have had
more reported success than SDS treatments recently, as
Erdbr¨ ugger et al. successfully implanted porcine pulmonary
valves in juvenile sheep and human models after a 1%
deoxycholic acid treatment. Likewise, Fang et al. successfully
decellularized porcine aortic valves with a protocol similar
to the selected TritonX-100/sodium-deoxycholate treatment
and subsequently recellularized the valves with endothelial
progenitor cells derived from human umbilical cord [35,International Journal of Biomaterials 3
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Figure 3: Uniaxial tensile system components and controllers.
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Figure 4: Experimental data plotted against curve ﬁts to nonlinear
material models.
36]. Deoxycholic acid treatments also show promise from a
mechanical standpoint, as a 4% deoxycholic acid solution
was used to decellularize canine common carotid artery
without signiﬁcant changes in compliance between native
and decellularized vessels [38].
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Figure 5: A representative plot of a paired data set and correspond-
ing curve ﬁts (4th load curve).
Though decellularization procedures produce acellu-
lar matrices that can be re-endothelialized with a host’s
autologous cells to minimize thrombosis when implanted
as a graft, these treatments have been shown to change
the mechanical compliance of arterial tissue [26, 37]. An4 International Journal of Biomaterials
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Figure 6: Typical ﬁnal experimental load curves for native and
acellular samples across all decellularization protocols tested.
engineered graft must not only remain biocompatible, but it
must also exhibit mechanical properties similar to the native
vasculature which it will replace [39, 40]. Diﬀering mechan-
ical behavior between the graft and native vasculature is
known as compliance mismatch. This condition creates local
ﬂow disturbances, which may lower the vessel wall shear
stress at the graft anastomosis and lead to the progressive
developmentofintimalhyperplasia,themostcommoncause
of occlusive graft failure [41–47].
To date, there have been several studies that have
investigated the mechanical eﬀects of decellularization on
vascular tissue segments [16, 20, 28, 37, 38, 48]. Some
studies compare vessel compliances under inﬂation loadings
[38, 48]. Other studies compare rupture properties of native
andacellularvessels,butdonotquantifydiﬀerencesobserved
inthe1.3 ≤ λz ≤ 1.6axialstretch rangeofload-displacement
curves [20, 28, 37], even though this is generally accepted as
the in vivo stretch range [49, 50]. These studies may also have
shortcomings in testing methodology that aﬀect reported
results.
One previous study compared native and acellular
porcine carotid artery lengths using inﬂation tests, but the
adventitial layer was removed to expedite the decellular-
ization process [37]. The eﬀect of decellularization on the
adventitia cannot be ignored, since certain detergents such
as SDS or deoxycholic acid may disrupt structural protein-
protein interactions [24]. Among the xenograft and allograft
studies previously mentioned, [20, 37] compared native and
acellular samples that had not been preconditioned, even
though results obtained from preconditioned soft tissue
samples are typically reported in order to minimize the
eﬀects of hysteresis [51]. The mechanical environment of
arteries was not fully considered in a study that compared
native and acellular arteries using compression testing [16];
because arterial tissue is in a constant physiological state
of tension due to systolic and diastolic pressures, arterial
tissue should be tested for changes in its tensile properties.
Though inﬂation testing is the current standard for deﬁning
anisotropic parameters for constitutive models of blood
vessels [37, 50, 52, 53], previous investigators report that
longitudinal strip samples of arterial tissue display charac-
teristic hyperelastic behavior [54–58]. This is to be expected,
since collagen and elastin ﬁbers are partially oriented in the
longitudinal direction.
Similar to arterial tissue, rubber exhibits nonlinear,
hyperelastic behavior at large strains. A parallel between
these materials’ behavior is the existence of chain-like
molecular structures; rubber is composed of polymer chains,
a n de a c ha r t e r i a ll a y e rh a so r i e n t e dﬁ b e r s[ 54]. Recently,
Martins et al. investigated the applicability of ﬁtting uniaxial
tensile data for silicone rubber and biological tissue to
popular material models [59]. They found that Yeoh, Ogden,
and Martins models ﬁt both sets of data with correlation
coeﬃcients higher than R = 0.99, which are considered very
good ﬁts. Martins et al. note that the Ogden and Martins
models are based on exponential functions, while the Yeoh
m o d e li sag e n e r a lh y p e r e l a s t i cf u n c t i o nw h i c hc a nﬁ ta
wide range of materials. The present investigation seeks to
improve upon the aforementioned biomechanical studies by
using paired samples of (i) intact vessel strips (ii) cut from
the same (longitudinal) location of an artery, wherein (iii)
both samples have identical stress histories, and (iv) the
mechanical data is quantiﬁed in terms of the entire stress
curve through a portion of the physiological stretch range.
2.MaterialsandMethods
Freshly excised segments of porcine aorta were trimmed
and sectioned longitudinally to make sets of paired samples.
Of these pairs, one sample was tested as a control (native)
and the other (acellular) underwent a decellularization
procedure. Multiple aortas were used in each protocol’s data
set, as shown in Table 1 .
2.1. Decellularization Protocols. P r o t o c o lAu s e sas o l u t i o n
of 1%w/w tert-octylphenyl-polyoxythylen (Triton X-100;
Fisher Scientiﬁc, Fair Lawn, NJ) and 0.02%w/w ethylene-
diaminetetraacetic acid (EDTA; Fisher Scientiﬁc Fair Lawn,
NJ), in Phosphate Buﬀered Saline solution (PBS; MA031,
A q u aS o l u t i o n s ,D e e rP a r k ,T X ) .S a m p l e sm a r k e df o r
decellularization were constantly agitated in this solution for
24 hours at 37◦Cw i t hR N a s eA( 2 0 μg/mL; Roche Diag-
nostics, Mannheim, Germany) and DNase I (0.2mg/mL;
Roche Diagnostics, Mannheim, Germany) before several
rinse cycles in PBS [27]. A minimal change is expected
with Protocol A, since Triton X-100 will disrupt lipid-lipid
and lipid-protein interactions while EDTA removes cellular
material by binding to divalent cations at cellular adhesion
integrins [24].
As speciﬁed in Schaner et al. [60], Protocol B uses
0.075%w/w sodium dodecyl sulfate (SDS; MP Biomedicals,
Solon, OH) in PBS. Samples marked for decellularization
were constantly agitated in this solution for 15 hours at
37◦C before ﬁve 15-minute rinse cycles in PBS at 37◦C.
Protocol B may induce a moderate change in the mechanical
properties of the tissue, as the hydrophobic-hydrophilic andInternational Journal of Biomaterials 5
ionicproperties ofSDScanalterprotein-protein interactions
by opening the molecular structure of elastin and disrupting
the hydrogen bonding of collagen [61].
The ﬁnal protocol tested, Protocol C, uses 0.25%w/w
Triton X-100 and 0.25%w/w sodium-deoxycholate (Fisher
Scientiﬁc, Fair Lawn, NJ) in PBS. Samples marked for
decellularization were constantly agitated in solution for 24
hoursat37◦Cbeforea72-hourwashcycleinM-199medium
(Mediatech, Inc., Herndon, VA) kept at 4◦C. Following the
wash cycle, the marked samples were treated with RNase A
(100μg/mL) and DNase I (150IU/mL) with 50mmol MgCl2
(Fisher Scientiﬁc, Fair Lawn, NJ) in PBS for 24 hours at
37◦C. After nuclease digestion, samples were again washed
with M-199 medium for 24 hours at 4◦C[ 34]. According
to a report comparing detergents used for decellularization
protocols, Protocol C may cause moderate to severe changes
in mechanical properties, since deoxycholic acid is regarded
as a more disruptive ionic detergent than SDS [24].
The same types of PBS, Triton X-100, RNase A, and
DNase I were used for applicable protocols throughout the
study.
2.2. Histological Methods. T h r e eh i s t o l o g i c a ls e c t i o n sw e r e
taken from diﬀerent sections of proximal (douter ≈ 12–
15mm) and distal (douter ≈ 10–12mm) acellular arterial
samples in each decellularization run, and compared to
native tissue in order to verify tissue decellularization.
Mechanical testing was not performed on the native and
acellular samples from which these histological sections
were taken. Samples were transferred to a 30% by weight
sucrose/PBS solution, embedded in Tissue-Tek OCT (Sakura
Finetek, Torrance, CA), and sectioned on a Reichert Jung
2800 Frigocut-E cryostat after sucrose saturation. Sections
with 15–20μm thickness were transferred to slides and
stained with a Mayer’s Hematoxylin and Eosin stain kit
(SL029; DakoCytomation, Carpinteria, CA). The stained
sections were then examined under a light microscope for
the presence of vascular smooth muscle cell nuclei.
2.3. Paired Sample Testing. Excised portions of aortic vessels
from adult pigs weighing 90–105kg were obtained from an
abbatoir (Kolb Brothers, Spring City, PA) and transported
in a 0.9% saline solution on ice for no more than two
hours. A 150mm aortic length that tapered in external
d i a m e t e rf r o m1 5 m mt o1 0 m mw a sr e m o v e df r o mt h e
artery. After being trimmed of connective tissue, the vessel
was cut with surgical scissors along its line of ventricles,
pressed ﬂat, and sectioned every 30mm. Paired, similar
10mm-wide longitudinal (axial) samples were made from
these sections (Figure 1). Each set of arterial samples
designated for decellularization was tested immediately after
the designated decellularization incubation periods speciﬁc
to each protocol.
2.3.1. Mechanical Testing Procedures. Prior to testing, the
thickness and width of each longitudinal artery sample
was measured at three points with a digital caliper. These
measurements were averaged and used to calculate each
sample’s cross-sectional area, Aavg.T h ee r r o rd u et ov a r i a -
tions in thickness and width of the samples is on the order
of 10%, but does not aﬀect the conclusion of this study
since the changes in mechanical behavior between native and
decellularized samples for all considered protocols is greater
than the range of error.
Each tensile specimen was loaded into notched stainless-
steel grips set 20mm apart. Digital caliper readings were
taken to determine the actual gage length in zero-stress state.
The sample was then immersed in an isotonic (154mmol
NaCl) saline bath within a plexiglas cylinder aﬃxed to the
base. The temperature of the bath was maintained at 38◦C
for 15 minutes prior to tensile loading. A force-displacement
curve was recorded at a strain rate of 0.1mm/s (1%/s)
for three preconditioning load-unload cycles and a ﬁnal,
fourth load-unload cycle that was analyzed. The four load-
unload hysteresis loops resulting from preconditioning and
theanalyzeddatasetareshowninFigure2,whereinthethird
and fourth loops overlap signiﬁcantly. Each loading cycle
ended at a longitudinal stretch ratio of approximately 1.50.
The stress concentration within the tissue near the serrated,
mated grips caused failure (tearing) at stretch ratios higher
than 1.50.
The experimental uniaxial tensile system (Figure 3)
consists of a linear actuator (D-A.083-HT17E5-4-1NO-/4;
UltraMotion,Cutchogue,NY)controlledbyasteppermotor
outﬁttedwithopticallyisolatedinputs(DR-4MPS;Advanced
Micro Systems, Nashua, NH). A signal conditioning con-
troller (SC-2350; National Instruments, Austin, TX) was
conﬁgured to output step signals to a stepper motor while
acquiring data from the linear actuator’s encoder and a load
cell (MDB-10; Transducer Techniques, Temecula, CA). The
accuracy of the load cell, calculated from uncertainties in
terms of its percentage of rated output, is within 0.2870 N
forallexperimentalmeasurementstaken.Thelinearactuator
was mounted in an inverted position and threaded rod
lengths connected the grips to the load cell and base of the
apparatus. The linear actuator encoder and load cell were
conﬁgured as DAQ inputs in a LabVIEW VI application
(National Instruments, Austin, TX).
2.3.2. Mechanical Data Analysis. Taking an approach similar
to Martins et al. [59], uniaxial data sets were ﬁt to several
rubber models and the variation of coeﬃcients between
paired native and acellular strip samples was considered.
Yeoh parameters varied the least among the material models.
For this purpose the Yeoh model is used to assess changes
in mechanical properties between native and decellularized
porcine aorta strips [62]. The stress states of the paired
samplesbeforedecellularizationareassumedtobeequal,and
axial stretch (λ) is computed from the reference length of
the vessel in the zero-stress state. The stress was computed
as engineering stress, which is the experimental force acting
on the plane of the cross-sectional area in the reference
conﬁguration,
σexperimental =
Fexperimental
A0,reference
. (1)6 International Journal of Biomaterials
In order to minimize the eﬀects of hysteresis in each
tissue sample, only the ﬁnal (fourth) loading curve was
analyzed. The stress-stretch data was normalized for stretch
values between 1.00 and 1.50. Using a least-squares analysis
in Excel, the Yeoh model function
σYeoh = 2

λ2 −
1
λ

c1 +c2(I1 −3)+c3(I1 − 3)
2
(2)
was used to ﬁt the data, where
I1 = λ2 +
2
λ
,( 3 )
and λ is the stretch ratio, I1 is the trace of the Right Cauchy-
Green tensor, and c1, c2,a n dc3 are ﬁtting constants deﬁned
in a least-squares analysis [59]. While ﬁtting the Yeoh model
to the data, there was no signiﬁcant change (ΔR<0.006) in
the quality of the ﬁt if c2 was excluded, so only the linear
Hookean term c1and the strain-hardening “hyperelastic”
term c3 were considered to simplify the analysis. Curve ﬁt
constantsweredeterminedbyﬁttingexperimentaldatatothe
modiﬁed Yeoh equation
σYeoh = 2

λ2 −
1
λ

c1 +c3(I1 −3)
2
. (4)
Resultsfromsamplepairswhosecurveﬁtscanbevisually
identiﬁed as inaccurate ﬁts or whose correlation coeﬃcients
(R) are less than 0.992 have not been considered. The
correlation coeﬃcient comparing two data sets is deﬁned as
C.C. = R =
n
i=1

fi − f

t

fi − f

e 
n
i=1

fi − f
2
t

n
i=1

fi − f
2
e
,( 5 )
where the subscripts t and e denote theoretical and experi-
mental values, respectively [63].
After c1 and c3 parameters were generated from curve ﬁts
to the experimental data, acellular constants were compared
to the native constants with the baseline parameter of
“percent change.” The concept of “percent change” was used
rather than absolute change because each paired sample
set is unique with respect to the site along the tapering
aortic length from which it was taken. This approach allows
the changes observed in both proximal and distal arterial
sections undergoing the same decellularization protocol to
be combined in a single data set.
Native samples were used as controls for each set and the
percentage change of acellular constants was analyzed. This
approach sets the native constants to 100% (unity):
(%Δci) =
Δci
(Δci)native
×100, i = 1,3. (6)
2.3.3. Statistical Methods. Paired, two-tailed t-test analysis
was used to assess the statistical signiﬁcance of percent
change for acellular samples based on c1 and c3 parameters.
The null hypothesis is that no diﬀerence exists between
mechanical properties of native and acellular tissue, with
P<.05 considered signiﬁcant and reason to reject the null
hypothesis. Two criteria, ranked in order of importance,
determinetheeﬀectivenessofadecellularizationprotocol:(i)
a narrow conﬁdence interval (±15%) and (ii) no statistical
signiﬁcance among diﬀerences in Yeoh coeﬃcients (P>
.05). More information and background on the statistical
methods used are given in the appendix.
3. Results
3.1. Optical Microscopy Results. Native arterial tissue was
stained as a comparison for determining the extent to which
vascular smooth muscle cells were removed from the tissue
by the decellularization treatment. Protocols A and B do
not eﬀectively decellularize the arterial tissue, as blue-stained
nuclei appeared in the H&E-stained sections much the same
astheyappearedinthenativetissuesection.ProtocolCis the
only protocol of the three that eﬀectively decellularizes the
tissue, and mechanical data was not included in the analysis
if the histological samples showed incomplete decellulariza-
tion.
Native vascular smooth muscle cell density was ∼
4600cells/mm2; for Protocol A, ∼4500cells/mm2,f o rP r o -
tocol B, ∼3800cells/mm2, and no cells were detected after
treatment with Protocol C.
3.2. Mechanical Testing Result. For comparison between the
exponentialMooney-Rivlin,Ogden,andMartinsmodelsand
the general form of the Yeoh model, curve ﬁts are plotted
against representative experimental data for a longitudinal
strip sample loaded in tension up to a stretch ratio of 1.50
(Figure 4).
Paired data sets were ﬁt to the Yeoh material model
(Figures 5 and 6). Data for c1 and c3 for each protocol,
including mean, P-value, and standard deviation (SD) are
presented in Tables 1 and 2. Incremental modulus values,
whichscalewith the c3 parameterof the modiﬁed Yeoh curve
ﬁt equation, are evaluated at λ = 1.49 and are included
in the extended data tables: Tables 3, 4,a n d5. Past studies
have identiﬁed the axial in vivo stretch ratio to be between
λ = 1.40 and λ = 1.50 [49, 50].
For parameter c1, Protocol A exhibits a very wide
conﬁdence interval [10.0% ± 26.5%] which envelopes the
upper and lower conﬁdence limits of Protocol C. Protocol B
[−19.1% ± 16.5%] exhibits a wider conﬁdence interval than
Protocol C [13.9% ± 13.9%]. Protocol C has the narrowest
conﬁdence interval of the three protocols, and changes are
not considered statistically signiﬁcant.
For parameter c3,P r o t o c o lA[ −27.9% ± 65.3%]
and Protocol B [8.5% ± 54.9%] do not show statistical
signiﬁcance, but both protocols exhibit signiﬁcantly wider
conﬁdence limits than Protocol C [−39.1% ± 27.7%]. Even
if Protocol C produces statistically diﬀerent results (P = .03),
the tissue’s “hyperelastic” behavior changes more predictably
in contrast to the eﬀects of other protocols.
4. Discussion
Xenografts and allografts may be used as alternatives to
stiﬀ biomaterial implants such as Dacron and ePTFE, butInternational Journal of Biomaterials 7
most current studies have overlooked compliance in the
physiologicalrange,haveﬂawsinexperimentalmethodology
thataﬀectreportedresults,orhavenotdirectlycomparedthe
mechanics of similar native and acellular tissues. Changes in
mechanicalpropertiesmayindicatedegradationoftheextra-
cellularmatrix thatwouldultimatelycausevesselthrombosis
as a result of local injury or trigger intimal hyperplasia
as a result of altered hemodynamics. Such changes were
investigated by analyzing diﬀerences between the mechanical
behavior of native and decellularized porcine descending
aorta. Curve ﬁts to experimental data (R>0.992) were
used to determine parameters for the Yeoh material model.
Changes in elastic and strain-hardening material response
could be inferred by changes in the model parameters,
allowing a quantitative comparison between the mechanics
of acellular and native tissues. The ultimate goal of this
study is to identify a decellularization procedure that either
minimally or predictably alters the mechanical behavior of
decellularized aorta at in vivo stretch ratios.
Drawing on the statistical analysis of the curve ﬁt
results, if a particular decellularization protocol has narrow
conﬁdence limits (±15%) and no statistical signiﬁcance
among sample diﬀerences (P>.05), the protocol does
not signiﬁcantly aﬀect the properties of the arterial tissue.
With respect to these standards for evaluating protocols
based on curve ﬁt parameters c1 and c3, tissue samples
treated with Protocol A and Protocol B resulted in the
highest variability in mechanical behavior, evidenced by
large standard deviations, and therefore large conﬁdence
intervals, in comparison to Protocol C. Based on this
statistical analysis, Protocol C is expected to decrease elastic
compliance and increase hyperelastic compliance. Though
Protocol C causes changes in mechanical behavior which
are statistically signiﬁcant, its narrow conﬁdence interval, in
comparison to other protocols, may indicate these changes
arerepeatable.Giventheseconditions,itispracticaltoignore
the statistical signiﬁcance of Protocol C when determining
the most eﬃcacious decellularization protocol.
Based upon the histological results, only Protocol C
eﬀectively lysed all vascular smooth muscle cells from the
extracellular matrix. After the initial results for Protocol A
and Protocol B tested positive for nuclei, the protocols were
repeated with seven times the original solution-to-tissue
volumetric ratio (222:1 increased from 30:1). Even at this
high volumetric ratio, decellularization did not occur.
Other biomechanical studies tested the eﬀects of
TritonX-100/EDTA, 0.05% SDS, and 0.1% SDS treatments
on porcine artery with similar results. Dahl et al. used
DNA quantiﬁcation tests to show that a TritonX-100/EDTA
protocol (Protocol A without RNase A) was ineﬀective at
removing cells from intima-media vessels, while a 0.05%
SDS treatment was eﬀective at cell removal [37]. The same
study showed decreased compliance of decellularized vessels,
though only rupture properties were statistically compared.
Additionally, since there were no signiﬁcant diﬀerences in
collagen quantiﬁcation between native and decellularized
vessels,collagendenaturationwasruledoutasacontributing
factor to alterations in mechanical compliance. In light of
these results, Dahl et al. posited that an alteration in vessel
compliance for the 0.05% SDS treatment was caused by the
absence of vascular smooth muscle cells [37]. This explana-
tion is incomplete at best, since the TritonX-100/EDTA and
SDS-treated vessels in their study display similar mechanical
behavior, even though the TritonX-100/EDTA treatment did
not decellularize the tissue. Similarly, Roy et al. used a 0.1%
SDS treatment in their biomechanical study and found that
the treated vessels were eﬀectively decellularized but had
a pronounced decrease in mechanical compliance under
inﬂation loadings [48]. However, Roy et al. attribute the
decrease in decellularized vessels’ distensibility to the early
engagement of collagen ﬁbers at low pressures [48].
Williams et al. compared the tensile properties of native
and decellularized rabbit carotid specimens, employing a
decellularization protocol using trypsin and ammonium
hydroxide[58].Small-anglelightscatteringwasusedtocom-
pare and relate native and acellular vessel ﬁber kinematics
to mechanical properties. They found that the collagen ﬁber
orientation was signiﬁcantly disrupted by the decellulariza-
tion process. Their decellularized arteries displayed a much
greater degree of stiﬀness than the uniaxially-tested strips
of [37] and our own study, though [37] mechanically tested
vessels without an adventitial layer. Williams et al. explained
that the increased stiﬀness occurred in decellularized arteries
as the randomized ﬁbers were recruited in the direction of
applied strain [58].
Based on our results and those of [37], it appears that
TritonX-100/EDTA treatments are less eﬀective at lysing cells
from porcine artery than SDS-based treatments. Both the
TritonX-100/EDTA and SDS-based treatments may decrease
compliance of vessels. However, the changes in compliance
following the selected TritonX-100/EDTA or SDS-based
treatments were signiﬁcantly less than the observed changes
in compliance following treatments utilizing trypsin and
ammonium hydroxide. The decrease in compliance may be
attributed to ﬁber recruitment in the direction of applied
strain or collagen denaturation as a result of the chemical
treatments. Though the porosity of decellularized segments
limited Williams et al. to uniaxial mechanical testing [58],
it would be of interest to see if changes resulting from
theirtrypsin/ammonium-hydroxideprotocolareasdramatic
during inﬂation testing, which would constrain randomized
ﬁbers from rotating into the direction of applied strain.
As a distinguishing aspect of this study, vessels treated
with the selected protocols have been reported to be suc-
cessfully decellularized and recellularized [27, 34, 60]. Decel-
lularization methods utilizing trypsin were not considered
because of reports of incomplete decellularization at short
(24 h) incubation times [64] or damage to the extracellular
matrix of vascular tissue at longer incubation times [33, 34,
58] unless the tissue is pretreated [65]. McFetridge et al.
showed that it is possible to stabilize the extracellular matrix
against excessive damage with a 75% ethanol pretreatment
[65]; because subsequent stages included crosslinking, this
protocol was not included among the enzymatic-detergent
cell extraction protocols tested.
Our results show that a TritonX-100/deoxycholic-acid
treatment originally proposed by Rieder et al. for decellular-
ization of porcine aortic valves [34], eﬀectively decellularizes8 International Journal of Biomaterials
Table 1: Breakdown of number of aortas used per tested protocol
and the number of samples derived from each aortic length.
Number of aortas Number of samples
(samples per aorta)
Protocol A 8 10 (1,1,1,1,1,1,1,3)
Protocol B 7 10 (1,1,1,1,2,2,2)
Protocol C 7 10 (1,1,1,1,2,2,2)
Table 2: Comparison of statistics for c1 among decellularization
protocols. Italics indicate statistical signiﬁcance (P<.05). Values
shown as percentages.
μ (90% C.L.) SD P
Protocol A (n = 10) 10.0( 2 6 .5) 51.60 .51
Protocol B (n = 10) −19.1( 1 6 .5) 28.70 .06
Protocol C (n = 10) 13.9( 1 3 .9) 24.20 .10
Table 3: Comparison of statistics for c3 among decellularization
protocols. Italics indicate statistical signiﬁcance (P<.05). Values
shown as percentages.
μ (90% C.L.) SD P
Protocol A (n = 10) −27.9( 6 5 .3) 125.20 .46
Protocol B (n = 10) 8.5( 5 4 .9) 95.90 .78
Protocol C (n = 10) −39.1( 2 7 .7) 48.2 0.03
Table 4: Extended data for Protocol A.
Sample Native Acellular
c1 c3
(dθ/dλ)|λ=1.49
(kPa)
c1 c3
(dθ/dλ)|λ=1.49
(kPa)
1 20.8 18.2 681 30.6 19.6 797
2 22.5 8.3 404 23.3 32.3 1112
3 20.0 61.1 1949 15.1 21.4 725
4 34.3 99.9 3191 17.8 33.5 1111
5 29.0 72.4 2402 23.5 27.4 987
6 31.3 42.2 1462 22.5 12.4 515
7 20.8 51.8 1711 42.7 10.7 616
8 29.3 45.0 1405 43.0 13.6 688
9 45.8 75.4 3084 41.9 11.9 840
10 30.8 67.7 3314 38.9 15.3 901
porcine descending aorta and induces minimal changes in
mechanical properties of porcine arterial tissue at stretch
ratios between 1.00 and 1.50. These results, along with those
of Murase et al. [38], suggest that deoxycholic acid treat-
ments eﬀectively preserve the native mechanical properties
and mechanical integrity of the aortic extracellular matrix
while lysing cellular components.
Table 5: Extended data for Protocol B.
Sample Native Acellular
c1 c3
(dθ/dλ)|λ=1.49
(kPa)
c1 c3
(dθ/dλ)|λ=1.49
(kPa)
1 31.1 22.1 837 25.8 67.0 1160
2 41.5 33.5 1253 30.6 15.9 639
3 25.4 24.7 903 19.5 38.6 1265
4 28.5 43.6 1486 4.6 6.7 229
5 42.4 112.5 3354 23.6 85.3 2708
6 30.9 22.6 890 30.3 75.6 2443
7 36.6 54.5 1921 30.5 22.7 885
8 27.8 22.8 856 31.9 25.8 995
9 21.1 41.2 1356 22.9 45.7 1527
10 20.0 60.3 1895 19.7 12.1 495
Table 6: Extended data for Protocol C.
Sample Native Acellular
c1 c3
(dθ/dλ)|λ=1.49
(kPa)
c1 c3
(dθ/dλ)|λ=1.49
(kPa)
1 13.6 46.5 1473 22.0 29.3 1044
2 20.1 34.3 1155 17.9 25.9 906
3 25.9 48.9 1667 32.3 34.0 1238
4 24.2 37.9 1278 22.6 11.3 504
5 29.8 46.0 1561 30.4 16.0 679
6 30.2 100.5 3196 29.7 37.8 1337
7 31.3 63.3 2097 36.5 17.8 784
8 16.9 96.5 2956 24.5 56.3 1796
9 27.7 103.7 3243 32.4 25.1 960
10 27.6 30.8 1097 25.4 57.8 1874
Appendix
StatisticalAnalysisDetails
The resulting changes in acellular samples were analyzed
with a two-tailed paired student’s t-test analysis, since the
data is expected to approximate a normal distribution. The
hypotheses for this test were
H0: (%Δcx)native −(%Δcx)acellular = 0, (A.1)
H1: (%Δcx)native −(%Δcx)acellular / =0( A . 2 )
for x = 1a n dx = 3.
The result of each t-test is represented by a t-statistic,
which is the number of “standard error of mean diﬀerence”
intervals along a t-distribution between the mean and zero.
The probability P of the null hypothesis H0 being true is
calculated as a relative measure between the observed and
critical t-statistics. If P<.05, zero does not lie within the
90% conﬁdence interval
C.I.90% = μ ±tα=0.05 ∗SE

d

,( A . 3 )International Journal of Biomaterials 9
and the null hypothesis (A.1) can be rejected. Note that
for paired sample t-testing, the critical t-value has (n − 1)
degrees of freedom. In (A.3), μ is the mean of the sample
set, tα=0.05 is the critical t-statistic, and SE(d) represents the
“standard error of the mean diﬀerences.” The standard error
of the mean diﬀerences can be calculated from the standard
deviation (SD) and number of samples n,a s
SE

d

=
(SD)
√
n
. (A.4)
The eﬀectiveness of a decellularization protocol will be
evaluated based on the range of its conﬁdence interval and
on statistical signiﬁcance of the diﬀerences in native and
acellular sample populations. Ideally, a protocol’s conﬁdence
interval should be narrow (±15%) and changes in the ﬁt
parameters should not be statistically signiﬁcant.
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